G.W. de Valk-de Roo

Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal Women

G.W. de Valk-de Roo, Coen D.A. Stehouwer, Piet Meijer et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 159 citations · Full text

Pharmacy, Endocrinology, Pharmacology +16

Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women

Velja Mijatovic, Coen Netelenbos, Marius J. van der Mooren et al. · Fertility and Sterility · 1998 · 84 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +11

Raloxifene Lowers Serum Lipoprotein(A) in Healthy Postmenopausal Women

Velja Mijatovic, Marius J. van der Mooren, Peter Kenemans et al. · Menopause The Journal of The North American Menopause Society · 1999 · 47 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Plasma Homocysteine Is Weakly Correlated with Plasma Endothelin and von Willebrand Factor but not with Endothelium-dependent Vasodilatation in Healthy Postmenopausal Women

G.W. de Valk-de Roo, Coen D.A. Stehouwer, J Lambert et al. · Clinical Chemistry · 1999 · 37 citations · Full text

Veterinary Medicine, Physiology, Hemostasis +12

Continuously combined hormone replacement therapy and bone turnover: the influence of dydrogesterone dose, smoking and initial degree of bone turnover

G.W. de Valk-de Roo, J. C. Netelenbos, Ieteke R.A Peters-Muller et al. · Maturitas · 1997 · 23 citations

Medicine, Endocrinology, Bone Metabolism +12